Celldex Therapeutics buy Barclays PLC
Start price
08.05.26
/
50%
€28.82
Target price
08.05.27
€40.93
Performance (%)
13.67%
Price
03.08.26
€32.52
Summary
This prediction is currently active. The prediction currently has a performance of 13.67%. This prediction currently runs until 08.05.27. The prediction end date can be changed by Barclays_PLC at any time. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Celldex Therapeutics | 6.728% | 6.728% |
| iShares Core DAX® | 2.334% | 1.011% |
| iShares Nasdaq 100 | 1.370% | -3.612% |
| iShares Nikkei 225® | 2.437% | -7.461% |
| iShares S&P 500 | 1.259% | 0.677% |
Comments by Barclays_PLC for this prediction
In the thread Celldex Therapeutics diskutieren
Celldex Therapeutics (CLDX) had its price target raised by Barclays PLC from $45.00 to $48.00. They now have an "overweight" rating on the stock.
Ratings data for CLDX provided by MarketBeat
Stopped prediction by Barclays_PLC for Celldex Therapeutics
Celldex Therapeutics
Start price
Target price
Perf. (%)
€29.16
20.04.26
20.04.26
€38.28
20.04.27
20.04.27
12.35%
03.08.26
03.08.26
Celldex Therapeutics
Start price
Target price
Perf. (%)
€21.80
17.12.25
17.12.25
€20.43
17.12.26
17.12.26
49.82%
03.08.26
03.08.26
Celldex Therapeutics
Start price
Target price
Perf. (%)
€20.80
11.11.25
11.11.25
€18.18
11.11.26
11.11.26
57.02%
03.08.26
03.08.26
Celldex Therapeutics
Start price
Target price
Perf. (%)
€23.20
13.10.25
13.10.25
€21.52
13.10.26
13.10.26
41.21%
03.08.26
03.08.26

